论文部分内容阅读
目的:探讨美托洛尔对缺血性心脏病心力衰竭患者心室重塑和心功能的影响。方法:选取2010年1月—2012年3月期间我院收治的232例缺血性心脏病心力衰竭患者,将其分为治疗组和对照组,对两组治疗前后疗效和症状改善情况进行比较。结果:与对照组相比,治疗组患者心室结构和心功能有较为明显的改善,组间比较存在统计学差异。结论:在常规心衰治疗的基础上加用美托洛尔治疗,临床效果较好,同时能明显改善心衰患者心室重塑和心脏功能,值得推广应用。
Objective: To investigate the effects of metoprolol on ventricular remodeling and cardiac function in patients with heart failure of ischemic heart disease. Methods: From January 2010 to March 2012 in our hospital, 232 cases of ischemic heart disease patients with heart failure were divided into treatment group and control group, the two groups were compared before and after treatment and the improvement of symptoms . Results: Compared with the control group, the ventricular structure and cardiac function in the treatment group were significantly improved, with statistical differences between the two groups. CONCLUSION: Metoprolol can be used on the basis of routine heart failure treatment, which has a good clinical effect and significantly improves ventricular remodeling and cardiac function in patients with heart failure. It is worth popularizing and applying.